R-(+)-propranolol for infantile hemangioma: β-adrenoceptor-independent mechanisms and clinical translation prospects.

Peng W, Chen F, Zheng Y, Zeng Y, Zhao Z, Liu Q, Liu H

Open source

DOI
10.3389/fmed.2026.1863768
Published
2026
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1863768,
  title = {R-(+)-propranolol for infantile hemangioma: β-adrenoceptor-independent mechanisms and clinical translation prospects.},
  author = {Peng W and Chen F and Zheng Y and Zeng Y and Zhao Z and Liu Q and Liu H},
  year = {2026},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2026.1863768},
  url = {https://doi.org/10.3389/fmed.2026.1863768}
}

RIS

TY  - JOUR
TI  - R-(+)-propranolol for infantile hemangioma: β-adrenoceptor-independent mechanisms and clinical translation prospects.
AU  - Peng W
AU  - Chen F
AU  - Zheng Y
AU  - Zeng Y
AU  - Zhao Z
AU  - Liu Q
AU  - Liu H
PY  - 2026
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2026.1863768
UR  - https://doi.org/10.3389/fmed.2026.1863768
ER  - 

APA

W, P., F, C., Y, Z., Y, Z., Z, Z., Q, L., & H, L. (2026). R-(+)-propranolol for infantile hemangioma: β-adrenoceptor-independent mechanisms and clinical translation prospects.. Frontiers in medicine. https://doi.org/10.3389/fmed.2026.1863768

Source records